← Back to Healthcare

Medical - Diagnostics & Research

Industry Overview

Stock Screener

Select filters to narrow down the 181 companies below

181 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

PT Prodia Widyahusada Tbk

PRDA.JK

PT Prodia Widyahusada Tbk

PRDA.JK
Market Cap $3.13T
Dividends 4.6%
P/E Ratio 14.5
Revenue $597B +7.8%
Net Income $48.3B +7.6%
Profit Margin +8.1%
Employees 2.91K
View Stock

Sai Life Sciences Limited

SAILIFE.NS

Sai Life Sciences Limited

SAILIFE.NS
Market Cap $409.56B
Dividends 0.0%
P/E Ratio 108.4
Revenue $6.59B +22.5%
Net Income $983M +17.3%
Profit Margin +14.9%
Employees 5.22K
View Stock

PT Diagnos Laboratorium Utama Tbk

DGNS.JK

PT Diagnos Laboratorium Utama Tbk

DGNS.JK
Market Cap $398.75B
Dividends 0.0%
P/E Ratio 235.8
Revenue $45.7B +10.3%
Net Income -$1.44B +176.8%
Profit Margin -3.2%
Employees 87
View Stock

Dr. Lal PathLabs Limited

LALPATHLAB.BO

Dr. Lal PathLabs Limited

LALPATHLAB.BO
Market Cap $331.63B
Dividends 0.9%
P/E Ratio 56.9
Revenue $8.74B +19.6%
Net Income $1.92B +27.6%
Profit Margin +22.0%
Employees 5.21K
View Stock

Dr. Lal PathLabs Limited

LALPATHLAB.NS

Dr. Lal PathLabs Limited

LALPATHLAB.NS
Market Cap $331.63B
Dividends 0.9%
P/E Ratio 56.9
Revenue $8.74B +19.6%
Net Income $1.92B +27.6%
Profit Margin +22.0%
Employees 5.21K
View Stock

H.U. Group Holdings, Inc.

4544.T

H.U. Group Holdings, Inc.

4544.T
Market Cap $217.47B
Dividends 3.1%
P/E Ratio 22.3
Revenue $63.2B -1.1%
Net Income $1.77B +24.3%
Profit Margin +2.8%
Employees 5.16K
View Stock

H.U. Group Holdings, Inc.

MRCHF

H.U. Group Holdings, Inc.

MRCHF
Market Cap $217.47B
Dividends 3.1%
P/E Ratio 22.3
Revenue $63.2B -1.1%
Net Income $1.77B +24.3%
Profit Margin +2.8%
Employees 5.16K
View Stock

BML, Inc.

4694.T

BML, Inc.

4694.T
Market Cap $148.44B
Dividends 3.2%
P/E Ratio 19.7
Revenue $39B +3.7%
Net Income $2.03B -13.9%
Profit Margin +5.2%
Employees 4.61K
View Stock

Vijaya Diagnostic Centre Limited

VIJAYA.BO

Vijaya Diagnostic Centre Limited

VIJAYA.BO
Market Cap $145.23B
Dividends 0.1%
P/E Ratio 71.2
Revenue $2.55B +26.7%
Net Income $595M +37.4%
Profit Margin +23.3%
Employees 2.51K
View Stock

Vijaya Diagnostic Centre Limited

VIJAYA.NS

Vijaya Diagnostic Centre Limited

VIJAYA.NS
Market Cap $145.23B
Dividends 0.1%
P/E Ratio 71.2
Revenue $2.55B +26.7%
Net Income $595M +37.4%
Profit Margin +23.3%
Employees 2.51K
View Stock

Metropolis Healthcare Limited

METROPOLIS.BO

Metropolis Healthcare Limited

METROPOLIS.BO
Market Cap $117.22B
Dividends 0.5%
P/E Ratio 52.2
Revenue $4.97B +15.8%
Net Income $753M +43.0%
Profit Margin +15.2%
Employees 4.48K
View Stock

Metropolis Healthcare Limited

METROPOLIS.NS

Metropolis Healthcare Limited

METROPOLIS.NS
Market Cap $117.22B
Dividends 0.5%
P/E Ratio 52.2
Revenue $4.97B +15.8%
Net Income $753M +43.0%
Profit Margin +15.2%
Employees 4.48K
View Stock

WuXi XDC Cayman Inc

2268.HK

WuXi XDC Cayman Inc

2268.HK
Market Cap $87.75B
Dividends 0.0%
P/E Ratio 48.3
Revenue $3.65B
Net Income $807M
Profit Margin +22.1%
Employees 2.66K
View Stock

Thyrocare Technologies Limited

THYROCARE.BO

Thyrocare Technologies Limited

THYROCARE.BO
Market Cap $79.26B
Dividends 1.9%
P/E Ratio 55.0
Revenue $2.71B +25.1%
Net Income $159M -66.9%
Profit Margin +5.9%
Employees 2.09K
View Stock

Thyrocare Technologies Limited

THYROCARE.NS

Thyrocare Technologies Limited

THYROCARE.NS
Market Cap $79.26B
Dividends 1.9%
P/E Ratio 55.0
Revenue $2.71B +25.1%
Net Income $159M -66.9%
Profit Margin +5.9%
Employees 2.09K
View Stock

WuXi AppTec Co., Ltd.

2359.HK

WuXi AppTec Co., Ltd.

2359.HK
Market Cap $66.5B
Dividends 1.4%
P/E Ratio 15.9
Revenue $16.6B +38.2%
Net Income $8.32B +136.7%
Profit Margin +50.0%
Employees 33.83K
View Stock

WuXi AppTec Co., Ltd.

603259.SS

WuXi AppTec Co., Ltd.

603259.SS
Market Cap $66.5B
Dividends 1.4%
P/E Ratio 15.9
Revenue $16.6B +38.2%
Net Income $8.32B +136.7%
Profit Margin +50.0%
Employees 33.83K
View Stock

WuXi AppTec Co., Ltd.

WUXAY

WuXi AppTec Co., Ltd.

WUXAY
Market Cap $66.5B
Dividends 1.4%
P/E Ratio 15.9
Revenue $16.6B +38.2%
Net Income $8.32B +136.7%
Profit Margin +50.0%
Employees 33.83K
View Stock

WuXi AppTec Co., Ltd.

WUXIF

WuXi AppTec Co., Ltd.

WUXIF
Market Cap $66.5B
Dividends 1.4%
P/E Ratio 15.9
Revenue $16.6B +38.2%
Net Income $8.32B +136.7%
Profit Margin +50.0%
Employees 33.83K
View Stock

Shin Nippon Biomedical Laboratories, Ltd.

2395.T

Shin Nippon Biomedical Laboratories, Ltd.

2395.T
Market Cap $51.58B
Dividends 4.0%
P/E Ratio 9.0
Revenue $9.7B +17.0%
Net Income $1.13B +41.6%
Profit Margin +11.7%
Employees 1.68K
View Stock